A study of the safety and efficacy of gatifloxacin in patients with bacterial conjunctivitis.

Trial Profile

A study of the safety and efficacy of gatifloxacin in patients with bacterial conjunctivitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Oct 2011

At a glance

  • Drugs Gatifloxacin (Primary)
  • Indications Gram-positive infections; Haemophilus infections; Infectious conjunctivitis
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 20 May 2010 Results reported in a Allergan media release.
    • 10 Jun 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
    • 10 Jun 2009 Actual patient number (859) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top